Literature DB >> 17490921

Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism.

D W Dempster1, R Müller, H Zhou, T Kohler, E Shane, M Parisien, S J Silverberg, J P Bilezikian.   

Abstract

By conventional 2-dimensional, histomorphometric analysis, we and others have previously shown that cancellous bone architecture is preserved in mild primary hyperparathyroidism (PHPT). We have now extended these observations to a 3-dimensional analysis using microcomputed tomography (microCT). Iliac crest bone biopsies were analyzed from the following subjects with PHPT: 22 postmenopausal women; 7 premenopausal women; similar numbers of normal pre- and postmenopausal women served as controls. Fifteen men with PHPT were also studied. Postmenopausal women with PHPT demonstrated features of preserved cancellous bone as shown by smaller age-related declines in cancellous bone volume (BV/TV) and connectivity density (Conn.D) and no change in bone surface/total volume (BS/TV) as compared to normal women. In postmenopausal women with PHPT, cancellous bone volume (BV/TV), bone surface/total volume, and connectivity density (Conn.D) were all higher, and trabecular separation (Tb.Sp) was lower than in postmenopausal controls. In sharp contrast to the findings in normal women, no structural variables in PHPT women were correlated with age. Also of note, there was no difference in any 3-dimensional index between women and men with PHPT. We conclude that three-dimensional, cancellous bone microarchitecture is preserved in patients with mild primary hyperparathyroidism.

Entities:  

Mesh:

Year:  2007        PMID: 17490921      PMCID: PMC2721277          DOI: 10.1016/j.bone.2007.03.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

1.  Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.

Authors:  Qingxiang Chen; Hiroshi Kaji; Mei-Fway Iu; Rikako Nomura; Hideaki Sowa; Mika Yamauchi; Tatsuo Tsukamoto; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

2.  Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.

Authors:  Yanfei L Ma; Qingqiang Zeng; David W Donley; Louis-Georges Ste-Marie; J Christopher Gallagher; Gail P Dalsky; Robert Marcus; Erik Fink Eriksen
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

3.  The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.

Authors:  M Parisien; S J Silverberg; E Shane; L de la Cruz; R Lindsay; J P Bilezikian; D W Dempster
Journal:  J Clin Endocrinol Metab       Date:  1990-04       Impact factor: 5.958

4.  Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods.

Authors:  P Christiansen; T Steiniche; A Vesterby; L Mosekilde; I Hessov; F Melsen
Journal:  Bone       Date:  1992       Impact factor: 4.398

5.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

6.  Trabecular bone remodeling and balance in primary hyperparathyroidism.

Authors:  E F Eriksen; L Mosekilde; F Melsen
Journal:  Bone       Date:  1986       Impact factor: 4.398

7.  Microstructure of the trabecula and cortex of iliac bone in primary hyperparathyroidism patients determined using histomorphometry and node-strut analysis.

Authors:  T Uchiyama; T Tanizawa; A Ito; N Endo; H E Takahashi
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

8.  Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.

Authors:  A B Hodsman; M Kisiel; J D Adachi; L J Fraher; P H Watson
Journal:  Bone       Date:  2000-08       Impact factor: 4.398

9.  Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.

Authors:  D W Dempster; F Cosman; E S Kurland; H Zhou; J Nieves; L Woelfert; E Shane; K Plavetić; R Müller; J Bilezikian; R Lindsay
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

10.  Skeletal disease in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; L de la Cruz; D W Dempster; F Feldman; D Seldin; T P Jacobs; E S Siris; M Cafferty; M V Parisien
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

View more
  41 in total

Review 1.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

2.  The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry.

Authors:  K E Barbour; J M Zmuda; M J Horwitz; E S Strotmeyer; R Boudreau; R W Evans; K E Ensrud; C L Gordon; M A Petit; A L Patrick; J A Cauley
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

Review 3.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

4.  Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.

Authors:  Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chiyuan Zhang; Rebecca Ives; Amanda Tulley; James Sliney; Serge C Cremers; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2012-11-15       Impact factor: 5.958

5.  Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.

Authors:  L C Pop; D Sukumar; S H Schneider; Y Schlussel; T Stahl; C Gordon; X Wang; T V Papathomas; S A Shapses
Journal:  Osteoporos Int       Date:  2016-08-17       Impact factor: 4.507

6.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

7.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

8.  Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Authors:  Barbara Campolina Silva; Stephanie Boutroy; Chiyuan Zhang; Donald Jay McMahon; Bin Zhou; Ji Wang; Julia Udesky; Serge Cremers; Marta Sarquis; Xiang-Dong Edward Guo; Didier Hans; John Paul Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

9.  Three dimensional cancellous bone structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; Thomas Kohler; Martin Stauber; Hua Zhou; Elizabeth Shane; Thomas Nickolas; Emily Stein; James Sliney; Shonni J Silverberg; John P Bilezikian; Ralph Müller
Journal:  Bone       Date:  2009-09-25       Impact factor: 4.398

Review 10.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.